GEFTIB 250MG

GEFTIB 250MG TABLET is classified as an ‘anti-cancer’ medication, primarily used for the treatment of lung cancer. Lung cancer is characterized by the uncontrolled proliferation of abnormal cells in one or both lungs. These abnormal cells fail to perform the normal functions of lung cells and do not form healthy lung tissue. In this condition, lung cells grow uncontrollably, and if not identified early, they may metastasize to other parts of the body, including the brain.

GEFTIB 250MG TABLET contains ‘Gefitinib’, which is part of a class of medications known as ‘kinase inhibitors’. It functions by inhibiting the activity of an abnormal protein that promotes the proliferation of cancerous cells. This mechanism helps to prevent the spread of cancerous cells.

It is important to take GEFTIB 250MG TABLET exactly as directed by your physician. You should continue taking GEFTIB 250MG TABLET for the duration prescribed by your doctor after evaluating your medical condition. Some patients may experience common side effects such as itching or skin rashes, acne, nail issues, vomiting, diarrhea, and decreased appetite. Most of these side effects are not serious and will gradually resolve. However, if these side effects persist, it is advisable to consult your doctor.

To effectively manage your condition, continue using GEFTIB 250MG TABLET for as long as your doctor recommends. Do not use GEFTIB 250MG TABLET if you are pregnant or planning to become pregnant, as it can lead to severe birth defects. Additionally, breastfeeding mothers should avoid GEFTIB 250MG TABLET since it can be transmitted through breast milk and may pose risks to the infant. Older adults may be more sensitive to this medication, so dosage adjustments may be necessary based on their health status. It is also recommended to refrain from consuming alcohol while taking GEFTIB 250MG TABLET, as it may increase the likelihood of dizziness.